Valion Bio Inc VBIO

US Health Care

$0.31 ▲ +11.51% (+$0.03)

⬆️ Above Yest. High 🎈 Low Float 🗓️ Earnings Next Week

Open $0.30

Prev Close $0.28

Day Range $0.26 – $0.36

52W Range $0.25 – $1.21

Market Cap $1.29M

Beta 3.57

EPS (TTM) $-8.23

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2021-11-11
Shares Out.	4,150,000
Website	tivichealth.com ↗
Phone	3026365401
Employees	52

About Valion Bio Inc

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Valion Bio Inc is a publicly traded company under the ticker symbol VBIO on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.